The News Review:
- SENATOR GRASSLEY COMMENTS ON THE INSTITUTE OF MEDICINE’S.
- Trends in evidence based medicine for herbal remedies and media…
- Wiley To Assume Publication Of Mount Sinai Journal Of Medicine
- Contribution a l’etude du paracelsisme en France au XVIe siecle…
- Hopkins Findings Could Extend The Life Of Transplanted Kidneys And…
- Farming for life, or pharmed to death?
SENATOR GRASSLEY COMMENTS ON THE INSTITUTE OF MEDICINE’S.
Free with registration - America's Intelligence Wire - AccessMyLibrary.com - Sep 22, 2006
Remember, the FDA only grudgingly requested this report to assess drug safety. Going forward, the Institute of Medicine’s assessment will add considerable muscle to the reform effort. Consumers shouldn’t have to second-guess what’s in their medicine cabinets. Access to life-saving, life-enhancing drugs doesn’t have to come at the expense of safety.
Trends in evidence based medicine for herbal remedies and media…
Free with registration - Health Law Review - AccessMyLibrary.com - Sep 22, 2006
Their use in Europe and North America is increasing significantly. (2) For example, a 1998 phone survey of 1539 adults found that 42. 1% in the United States had used at least one CAM within a twelve month period and that use had increased since 1990; the most used treatments were herbal medicine, massage, megavitamins, self-help groups, folk remedies, energy healing and homeopathy. (4) Users of CAM are more likely to have higher education levels and report lower health status. (5) Common health problems treated with CAM are anxiety, back problems, chronic pain, and urinary tract problems. Use of CAM is dependent, not on dissatisfaction with conventional medicine as it is most commonly used in association with conventional medicine, but on philosophical orientations towards health and life, such as feminism, spirituality, and personal growth… A vast quantity of information of varying quality exists in the media and on the internet. (8) There are concerns, however, that the media and internet provide too rosy a picture of CAM (9) and downplay adverse reactions to CAM, which can be dangerous and potentially fatal. (10) Such coverage augments the common misperception that CAM is natural and therefore, less harmful than conventional medical treatments. (11) Indeed, Barnes et al. (1998) found that users of CAM were less likely to report adverse effects than users of over-the-counter medicines. (12) These factors suggest that significant improvements need to be made to knowledge translation mechanisms for the public, healthcare professionals, and policy makers. The response of the medical and scientific community.
Wiley To Assume Publication Of Mount Sinai Journal Of Medicine
Medical News Today - Sep 22, 2006
, today announced an agreement with the Mount Sinai School of Medicine whereby Wiley will assume publishing responsibilities for Mount Sinai Journal of Medicine. Wiley will re-launch the journal in January 2007 with a completely new design and editorial focus. Published continuously since 1934 by The Mount Sinai Hospital in New York, Mount Sinai Journal of Medicine is issued six times a year and features clinical articles from all medical disciplines. Wiley will re-launch the journal as Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine featuring articles on the evolving nature of clinical care; its close linkage to bio-medical research; and resulting opportunities for enhanced patient outcomes. The new editorial focus reflects the growing importance of translational and personalized medicine. “Wiley feels strongly that this journal with a long history has a bright future,” said Shawn Morton, Vice President and Publishing Director, Medicine, John Wiley & Sons, Inc… Wiley will re-launch the journal in January 2007 with a completely new design and editorial focus. Published continuously since 1934 by The Mount Sinai Hospital in New York, Mount Sinai Journal of Medicine is issued six times a year and features clinical articles from all medical disciplines. Wiley will re-launch the journal as Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine featuring articles on the evolving nature of clinical care; its close linkage to bio-medical research; and resulting opportunities for enhanced patient outcomes. The new editorial focus reflects the growing importance of translational and personalized medicine. “Wiley feels strongly that this journal with a long history has a bright future,” said Shawn Morton, Vice President and Publishing Director, Medicine, John Wiley & Sons, Inc. “We see great value in disseminating translational research to support personalized medicine and look forward to working with Mount Sinai to position Mount Sinai Journal of Medicine as a leading forum for the publication of clinical research highly relevant to clinical practice. Each issue of the journal will contain review articles - invited and submitted - from distinguished guest authors from U.
Contribution a l’etude du paracelsisme en France au XVIe siecle…
Free with registration - Renaissance Quarterly - AccessMyLibrary.com - Sep 22, 2006
ISBN: 2-7453-1205-7. Taken together, these two volumes make a useful contribution to the history of Paracelsian medicine in sixteenth-century France. Baudry treats the history of medicine as a form of intellectual history, and his primary concern is with the transmission and reception of Paracelsian concepts rather than with the practice of medicine. The Contribution is a reworking of Baudry’s doctoral thesis from 1989 and is therefore not a recent work. In a short preface, Didier Kahn includes references to recent works in the field, but neither Baudry’s text nor his bibliography has been updated. As a dissertation, it typifies the careful and detailed scholarship of French academia.
Hopkins Findings Could Extend The Life Of Transplanted Kidneys And…
Medical News Today - Sep 22, 2006
Researchers have long known that when blood flow is cut off and then returned to transplanted kidneys or other organs, immune system cells called T lymphocytes produce toxic natural chemicals that contribute to ischemic reperfusion injury (IRI). Nature cannot distinguish between deliberate surgical wounds needed to remove and re-implant a donor kidney and other kinds of organ damage in which certain toxic chemicals are needed to clean up or remove bad tissue. But in the new study published in the September issue of The Journal of Immunology, the Hopkins team reports that that T cells can also play a role in reducing cellular damage in IRI kidneys, according to Hamid Rabb, M. , medical director of kidney and pancreas transplantation at The Johns Hopkins University School of Medicine. IRI occurs in 30 percent to 40 percent of kidneys removed from dead donors, resulting in lower kidney survival rates, shortened kidney life and a cost increase of approximately $20,000 per patient from the initial hospital stay and treatment alone, according to Rabb… But in the new study published in the September issue of The Journal of Immunology, the Hopkins team reports that that T cells can also play a role in reducing cellular damage in IRI kidneys, according to Hamid Rabb, M. , medical director of kidney and pancreas transplantation at The Johns Hopkins University School of Medicine. IRI occurs in 30 percent to 40 percent of kidneys removed from dead donors, resulting in lower kidney survival rates, shortened kidney life and a cost increase of approximately $20,000 per patient from the initial hospital stay and treatment alone, according to Rabb. Scientists therefore are interested in identifying means of preventing or rapidly treating IRI, but one barrier to greater understanding has been the inability to detect the lymphocytes in the kidney during the first critical six hours after blood flow is returned. In the Hopkins study, designed to try to find these cells and learn more about IRI, white blood cells were taken from mice that had undergone experimentally induced IRI. These cells were injected into mice engineered without a thymus gland, which produces T cells.
Farming for life, or pharmed to death?
Capital Press - Capital Press (subscription) - Sep 22, 2006
If it weren’t for America’s foolhardy War on Drugs, there would be no question at all. For eons, herbs have been successfully cultivated for a wide variety of medicinal uses. The line between farmer and healer - or shaman - should be blurry. More than any other factor, what defines the traditional farmer is not the size of his land, but his role in life and death… Biologics, which describes a class of drugs derived from biological material, makes up a growing percentage of pharmaceuticals. Currently they are produced through genetically engineered animals, but the expense and inefficiency of this production method has spawned plant-derived biologics instead. In “Biohazards: The Next Generation? Genetically Engineering Crop Plants That Manufacture Industrial and Pharmaceutical Proteins,” Brian Tokar says concerns go beyond the familiar cross-pollination issues: “We may soon see biologically active enzymes and pharmaceuticals, usually only found in nature in minute quantities - and usually biochemically sequestered in very specialized regions of living tissues and cells - secreted by plant tissues on a massive commercial scale. ” By now we have an all-too-long list of failures to contain genetically engineered crops. And though plant-derived pharmaceuticals aren’t even on the market yet, their containment is already a problem. In 2002, ProdiGene’s pharma-corn, containing an experimental pig vaccine, contaminated soybeans in Iowa and Nebraska. New regulations were then put in place, prompting Monsanto to announce its departure from the biopharming industry.
Leave a Comment